<DOC>
	<DOCNO>NCT02911545</DOCNO>
	<brief_summary>Non-vitamin K oral anticoagulant ( NOAC ) show safe effective alternative warfarin stroke prevention patient nonvalvular AF ( NVAF ) . There yet limit real life data outcome follow elective cardioversion AF patient treat NOACs . The aim study investigate complication use NOACs AF patient undergo cardioversion .</brief_summary>
	<brief_title>Non-vitamin K Oral Anticoagulants Cardioversion</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>AF patient undergo cardioversion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Cardioversion</keyword>
</DOC>